ClinicalTrials.Veeva

Menu
E

Esperanza Clinical | Murrieta, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

NEU-411
AR1001
[18F]PI-2620
JNJ-64042056

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620...

Enrolling
Alzheimer Disease
Drug: [18F]PI-2620

The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's...

Enrolling
Idiopathic Parkinson Disease
Early Parkinson Disease (Early PD)
Other: Placebo
Drug: NEU-411

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Comp...

Enrolling
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Trial sponsors

A
Janssen (J&J Innovative Medicine) logo
L
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems